Metovia is launching soon. We are not yet accepting patients — join the waiting list and we’ll be in touch as soon as we open.
LAUNCHING SOON

Doctor-led weight loss,
launching soon.

Medically supervised, doctor-led GLP-1 weight-loss treatment delivered online, with a full medical assessment and ongoing monitoring. Metovia is launching soon; join the waiting list and we'll be in touch as soon as we open.

Check my eligibility → Join the waiting list →
✓
GMC Registered
✓
FFPM Qualified
✓
NICE-Guided Prescribing
Why patients choose Metovia

Doctor-led weight management,
done properly.

Metovia is built around careful, doctor-led care from start to finish. Here's what that means for you.

🩺

A full doctor-led assessment

Every patient is assessed by a GMC-registered doctor. Your medical history, blood results and individual risk factors are all reviewed before any treatment decision is made.

🔬

Safe, appropriate prescribing

Treatment is only recommended where it is clinically appropriate for you. Prescribing follows recognised clinical guidance, with the right dose and a clear plan tailored to your needs.

📈

Ongoing monitoring and support

Your care continues after your first appointment. Regular check-ins, blood monitoring at key intervals and messaging support help keep your programme safe and on track.

Metovia will be doctor-led and guided by recognised clinical standards, taking you from consultation through to a personalised programme. Launching soon.
How treatment works

GLP-1 weight-loss treatment — what the science says

GLP-1 based weight-loss treatments are extensively trialled and prescribed only after a full medical assessment by Dr Qurbain, where they are clinically appropriate for you.

How it works

GLP-1 treatment

Typically a weekly injection

~15%
Average body weight loss reported in clinical trials of GLP-1 treatment
  • Works on the GLP-1 pathway to reduce appetite and slow gastric emptying
  • Usually a weekly subcutaneous injection, self-administered
  • Started at a low dose and gradually titrated to a maintenance dose
  • Generally considered for a BMI ≥ 30, or ≥ 27 with a weight-related condition
  • Suitability is always confirmed on an individual basis
How it works

Dual-pathway GLP-1 treatment

Typically a weekly injection

~20%
Average body weight loss reported in clinical trials of dual-pathway treatment
  • Works on two complementary gut-hormone pathways to support appetite control
  • Usually a weekly subcutaneous injection, self-administered
  • Started at a low dose and gradually titrated to a maintenance dose
  • Generally considered for a BMI ≥ 35, or ≥ 30 with a weight-related condition
  • Among the more effective options in clinical trials to date
Dr Qurbain will recommend the most appropriate treatment based on your full medical assessment, including your BMI, metabolic profile, medical history and personal preferences.
Eligibility checker

Am I eligible?

Use the calculator below to get an instant indication. BMI is one factor — your full eligibility is assessed by Dr Qurbain at consultation.

Height
Weight
—
Your BMI
✅
You are likely eligible for GLP-1 therapy. Join the waiting list →
⚠️
You may be eligible with a weight-related health condition (e.g. type 2 diabetes, hypertension). Join the waiting list →
ℹ️
GLP-1 therapy is not currently indicated at your BMI. Dr Qurbain offers metabolic health consultations to support healthy weight management.

This is an indicative check only. Final eligibility is determined by Dr Qurbain at consultation, taking into account your full medical history and any weight-related health conditions.

The programme

Your programme, step by step

1
Today

Book online

Choose your appointment slot. Complete a pre-consultation questionnaire covering your weight history, medical history, current medications and lifestyle. This takes around 10 minutes and gives Dr Qurbain everything needed to make your consultation as effective as possible.

2
Before your appointment

Blood tests

Order a home blood test kit from one of our recommended partners. Results are typically back in 3–5 days. We review HbA1c, fasting glucose, lipids, thyroid function, liver function and kidney function — a comprehensive metabolic panel to ensure safe and appropriate prescribing.

3
Once your results are ready

Video consultation with Dr Qurbain

A 45-minute one-to-one video consultation. Dr Qurbain reviews your full metabolic profile, discusses your goals and health history, answers your questions and agrees your programme. If appropriate, your prescription is issued during or immediately after this appointment.

4
After your consultation

Prescription & medication

Your electronic prescription will be sent to your chosen registered UK pharmacy. Medication will be delivered directly to your door. You will also receive a supervised titration schedule — a clear, personalised plan for dose increases over your programme.

5
Ongoing

Monthly monitoring

A quick monthly check-in in the Metovia app, reviewed by Dr Qurbain, with a video call whenever needed. Dose titration as needed, prescription renewal, blood monitoring at key intervals, and messaging support between check-ins. Your progress is tracked in the app throughout your programme.

Pricing

One monthly price for your care and treatment.

No joining fee and no separate consultation charges. Your plan covers your doctor, your treatment if prescribed, delivery and ongoing support. Home blood tests, when needed, are ordered separately from our recommended partners.

Step 1
Online health assessment
Free
About 5 minutes · no obligation
  • ✓
    Quick health and eligibility questions
  • ✓
    Instant BMI check
  • ✓
    Reviewed personally by Dr Qurbain
  • ✓
    You pay nothing unless treatment is right for you
Join the waiting list →
All-inclusive monthly plan
Doctor-led weight programme
From £199/month
Price depends on your treatment and dose, and is always agreed with you first
  • ✓
    Video consultation with Dr Qurbain, a GMC-registered doctor
  • ✓
    Personalised plan, with prescription only where clinically appropriate
  • ✓
    Treatment dispensed by a registered UK pharmacy
  • ✓
    Tracked, temperature-controlled home delivery
  • ✓
    Monthly check-in reviewed by Dr Qurbain
  • ✓
    Secure messaging and the Metovia app to track your progress
Join the waiting list →
How payment works
Fair and flexible
No lock-in
Stop or pause whenever you choose
  • →
    Nothing to pay until the doctor confirms treatment is right for you
  • →
    Each month is only charged after your check-in is approved
  • →
    Monthly plans range from £199 to £389, depending on treatment and dose
  • →
    Secure card payments, including Apple Pay and Google Pay
  • →
    No hidden fees — any blood tests are explained and priced before you order
Read FAQs →

Most patients begin seeing results — reduced appetite, improved energy — within 4–8 weeks of starting treatment.

Your doctor

About Dr Qurbain

Dr Anzal Qurbain
Dr Anzal Qurbain
Dr Anzal Qurbain
MBBS BSc(Hons) MBA FFPM
GMC Registration: 4369286

Dr Qurbain is a Fellow of the Faculty of Pharmaceutical Medicine (FFPM) — one of approximately 700 in the UK. This qualification represents the highest level of expertise in pharmaceutical medicine, covering drug development, clinical pharmacology and evidence-based prescribing. Fellowship is awarded only to doctors who have passed a rigorous professional examination and demonstrated sustained expertise in the discipline.

Every Metovia patient will be assessed and prescribed by a doctor with specialist pharmaceutical medicine qualifications. Dr Qurbain will review your full metabolic picture — not just your weight. Blood results, medication history, comorbidities and risk factors will all be considered before any prescription is issued.

Dr Qurbain has worked across the pharmaceutical industry with major manufacturers of GLP-1 medications and has a deep understanding of the clinical evidence base, safety profile and optimal use of these treatments. This specialist knowledge directly informs the quality and rigour of prescribing decisions made at Metovia.

Frequently asked questions

Questions & answers

Yes. GLP-1 medications have been through extensive clinical trials involving tens of thousands of patients and are NICE-approved for use in the UK. Dr Qurbain conducts a full medical assessment — including blood panel review — before prescribing, and monitors you throughout your treatment programme to ensure safety and appropriate dose titration.
At Metovia, your care includes a comprehensive blood panel review before your appointment, a 45-minute one-to-one video consultation with a doctor who holds specialist pharmaceutical medicine qualifications, a personalised programme and titration schedule, and ongoing monthly monitoring. This is the standard of care that doctor-led GLP-1 treatment involves.
Dr Qurbain will explain exactly why treatment is not appropriate for you and discuss alternative metabolic health support options. You are only charged for a monthly plan if treatment is started — the online assessment is free.
Clinical trials of GLP-1 based weight-loss treatments report an average of around 15% total body weight loss over roughly 68 weeks, with dual-pathway treatment reporting around 20% over roughly 72 weeks. Most patients notice meaningful appetite suppression within the first 2–4 weeks of treatment. Individual results vary depending on starting weight, dose, adherence and lifestyle factors.
No. The entire Metovia programme will be delivered online. Consultations will be conducted by video, blood tests completed using a home testing kit, prescriptions electronic, and medication delivered to your door. You will receive the same standard of medical care without needing to travel.
Yes. Private prescribing through Metovia is entirely legal and is carried out by a GMC-registered doctor following a full medical assessment, in line with recognised clinical guidance. Treatment is only provided where it is clinically appropriate for you. Metovia is launching soon — join the waiting list to be notified when we open.
We recommend an at-home blood test covering HbA1c (to check for diabetes), fasting glucose, lipid profile (cholesterol), thyroid function, liver function and kidney function. This comprehensive metabolic panel provides the clinical information Dr Qurbain needs to prescribe safely. We can recommend a home testing kit provider at the time of booking.
Most patients use GLP-1 therapy for 12–24 months while establishing sustainable healthy habits and reaching their target weight. Research suggests that weight regain can occur after stopping treatment, particularly without lifestyle changes. Dr Qurbain will review the ongoing need for medication at every monthly monitoring appointment and discuss the appropriate exit strategy for your circumstances.
Launching soon

Metovia is launching soon.
Join the waiting list.

Doctor-led. NICE-guided. We are not yet accepting patients — join the waiting list and we'll be in touch as soon as we open.

Join the waiting list →

Or email hello@metovia.co.uk with any questions